MAPT and Alzheimer disease: In the case of AD, markers such as inflammation, neurodegeneration as well as amyloid beta deposits and hyperphosphorylated tau aggregates have been reported to appear in the retina of patients even at an early stage [10] although controversial findings have also been published [13].